Lantus Solostar is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Insulin Glargine.
Product ID | 0088-2219_0a57f187-f101-4268-851f-7f20c7f708f9 |
NDC | 0088-2219 |
Product Type | Human Prescription Drug |
Proprietary Name | Lantus Solostar |
Generic Name | Insulin Glargine |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2009-09-23 |
Marketing Category | BLA / NDA |
Application Number | BLA021081 |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | INSULIN GLARGINE |
Active Ingredient Strength | 100 [iU]/mL |
Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2009-09-23 |
NDC Exclude Flag | N |
Sample Package? | Y |
Marketing Category | BLA |
Application Number | BLA021081 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2009-09-23 |
Marketing Category | BLA |
Application Number | BLA021081 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2020-03-30 |
Marketing Category | BLA |
Application Number | BLA021081 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2009-09-23 |
Ingredient | Strength |
---|---|
INSULIN GLARGINE | 100 [iU]/mL |
SPL SET ID: | d5e07a0c-7e14-4756-9152-9fea485d654a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0088-2219 | Lantus Solostar | insulin glargine |
70518-1390 | Lantus Solostar | Lantus Solostar |
0088-5020 | Lantus Solostar | Lantus Solostar |
50090-1398 | Lantus Solostar | Lantus Solostar |
0002-7715 | BASAGLAR | Insulin glargine |
0002-8214 | BASAGLAR | Insulin glargine |
0088-2220 | Lantus | insulin glargine |
0024-5869 | TOUJEO | insulin glargine |
0024-5871 | TOUJEO Max | insulin glargine |